Course: Attitudes and Factors Associated With COVID-19 Vaccine Hesitancy Among Patients With Breast Cancer
CME Credits: 1.00
Released: 2021-06-10
The COVID-19 pandemic has had a substantial effect on cancer care. The recent widespread availability of vaccines against SARS-CoV-2 is a promising strategy to prevent COVID-19–associated mortality. However, previous reports have shown a high hesitancy rate to receive a COVID-19 vaccine among oncologic patients., Because breast cancer is the most commonly diagnosed malignant neoplasm, it is imperative to evaluate the specific concerns regarding COVID-19 vaccination among patients with this disease.
Educational Objective
To identify the key insights or developments described in this article
View Full Course